Related Experiment Video

Updated: Jun 20, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

[Systemic lupus erythematosus and Epstein-Barr virus]

I Tazi1, S Fehri, K Elghrari

  • 1Laboratoire d'Hématologie, CHU Ibn Rochd, Casablanca, Maroc. Tazi_illias@hotmail.com

Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|September 8, 2009
PubMed

Insights

This study found no significant difference in Epstein-Barr virus (EBV) antibody prevalence between systemic lupus erythematosus (SLE) patients and healthy controls. Antibody levels suggest EBV infection is common in both groups, not a distinguishing factor for SLE.

Area of Science:

  • Immunology
  • Virology
  • Rheumatology

Background:

  • Epstein-Barr virus (EBV) is a common human herpesvirus.
  • The role of EBV in the pathogenesis of systemic lupus erythematosus (SLE) remains unclear.
  • Investigating EBV antibody profiles may offer insights into SLE etiology.

Purpose of the Study:

  • To determine and compare the prevalence of antibodies to Epstein-Barr virus (EBV) in patients with SLE and healthy controls.
  • To assess if specific EBV antibody types or levels differ between SLE patients and controls.

Main Methods:

  • Case-control study design.
  • Serological testing for EBV antibodies including IgM anti-viral capsid antigen (VCA), IgG anti-VCA, and IgG anti-EBNA1.
  • Comparison of antibody prevalence and mean immunity ratios between 44 SLE patients and 44 age- and sex-matched healthy controls.

Main Results:

  • No significant difference in IgM anti-VCA prevalence (9% vs. 11%, P = 0.9).
  • High IgG anti-VCA prevalence in both groups (100% vs. 91%, P = 0.12), with a trend towards higher mean immunity ratio in SLE cases (2.341 vs. 1.873, P = 0.068).
  • Similar IgG anti-EBNA1 prevalence (91% vs. 95%, P = 0.6).

Conclusions:

  • The prevalence of antibodies to Epstein-Barr virus (EBV) is not significantly different between SLE patients and healthy controls.
  • High seroprevalence of IgG anti-VCA suggests widespread past EBV infection in both groups.
  • EBV infection status, based on these antibodies, does not appear to be a distinguishing factor for systemic lupus erythematosus.

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...